Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

EOLS

Evolus (EOLS)

Evolus Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EOLS
DateTimeSourceHeadlineSymbolCompany
05/20/20247:30AMBusiness WireEvolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE MeetingNASDAQ:EOLSEvolus Inc
05/15/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
05/15/20247:30AMBusiness WireEvolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO SummitNASDAQ:EOLSEvolus Inc
05/14/20247:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
05/14/20247:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
05/14/20247:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
05/10/20245:55PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
05/10/20248:10AMBusiness WireEvolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the YearNASDAQ:EOLSEvolus Inc
05/07/20244:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EOLSEvolus Inc
05/07/20243:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
05/07/20243:05PMBusiness WireEvolus Reports First Quarter 2024 Results and Provides Business UpdateNASDAQ:EOLSEvolus Inc
04/23/20243:30PMBusiness WireEvolus to Report First Quarter Financial Results on May 7, 2024NASDAQ:EOLSEvolus Inc
04/17/20243:05PMBusiness WireEvolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®NASDAQ:EOLSEvolus Inc
04/12/20243:05PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
03/26/20247:00AMBusiness WireEvolus to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:EOLSEvolus Inc
03/11/20248:00AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EOLSEvolus Inc
03/11/20246:00AMBusiness WireEvolus Announces Pricing of $50.0 Million Underwritten Offering of Common StockNASDAQ:EOLSEvolus Inc
03/08/20243:05PMBusiness WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
03/07/20243:58PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EOLSEvolus Inc
03/07/20243:42PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EOLSEvolus Inc
03/07/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
03/07/20243:05PMBusiness WireEvolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 GuidanceNASDAQ:EOLSEvolus Inc
03/01/20247:30AMBusiness WireEvolus Announces Results from European Head-to-Head Filler TrialNASDAQ:EOLSEvolus Inc
02/27/20247:30AMBusiness WireEvolus to Participate in Upcoming Leerink Partners and Barclays Investor ConferencesNASDAQ:EOLSEvolus Inc
02/23/20247:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
02/23/20247:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
02/22/20243:30PMBusiness WireEvolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024NASDAQ:EOLSEvolus Inc
02/09/20245:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
02/09/20245:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
02/09/20245:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
 Showing the most relevant articles for your search:NASDAQ:EOLS